Portal is building the universal infrastructure for cell engineering across drug discovery and cell therapy. Our proprietary mechanical delivery system enables efficient, scalable delivery of RNA, gene editors, probes, and other molecules into hard-to-transfect cells across many cell types and workflows.
The Portal Galaxy system seamlessly integrates with the Opentrons Flex TM system, increasing throughput, reducing manual effort, and minimizing user error. This combination brings Portal’s unique capabilities to higher throughput settings, including primary cell CRISPR screens, novel drug discovery and hit identification assays, all while maintaining cell viability and function.
